This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: The nurse recognizes that when a client is receiving a lipid-soluble medication, higher ... (Read 70 times)

sarasara

  • Hero Member
  • *****
  • Posts: 521
on: Jul 23, 2018
The nurse recognizes that when a client is receiving a lipid-soluble medication, higher concentrations will accumulate in which tissues?
 
  1. Cardiac muscle
  2. Liver
  3. Bone marrow
  4. Skeletal muscle

Question 2

When administering a drug-proteinbound drug to a client, what can the nurse expect?
 
  1. Duration of action will be prolonged.
  2. Drug excretion will be accelerated.
  3. Metabolism of the drug will be delayed.
  4. Onset of drug action will be prolonged.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

TDubDCFL

  • Sr. Member
  • ****
  • Posts: 357
Reply #1 on: Jul 23, 2018
Answer to Question 1

Correct Answer: 3
Rationale 1: Lipid-soluble drugs do not have greater affinity for cardiac muscle tissue.
Rationale 2: Lipid-soluble drugs do not have greater affinity for the liver.
Rationale 3: Lipid-soluble drugs have a higher affinity for bone marrow, teeth, the eye, and adipose tissue.
Rationale 4: Lipid-soluble drugs do not have greater affinity for skeletal muscle tissue.
Global Rationale: Lipid-soluble drugs have a higher affinity for bone marrow, teeth, the eye, and adipose tissue. There is not greater affinity for cardiac muscle tissue, the liver, or in the skeletal muscle tissue.

Answer to Question 2

Correct Answer: 1
Rationale 1: The portion of the drug that is protein bound is not available to the tissues, but as it is released, it becomes a free drug; a drug that is highly protein-bound has a high percentage of bound or unavailable drug that will produce a longer duration of action.
Rationale 2: Drug excretion will not be accelerated.
Rationale 3: Metabolism of the drug will occur as the free drug portion becomes available.
Rationale 4: Onset of action of the drug will not be affected.
Global Rationale: The portion of the drug that is protein bound is not available to the tissues, but as it is released, it becomes a free drug; a drug that is highly protein bound has a high percentage of bound or unavailable drug that will produce a longer duration of action. Drug excretion will not be accelerated. Metabolism of the drug will occur as the free drug portion becomes available. Onset of action of the drug will not be affected.


sarasara

  • Member
  • Posts: 521
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review

Mochi

  • Member
  • Posts: 300
Reply 3 on: Yesterday
Gracias!

« previous next »
 

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Injecting an IV push (bolus) medication; C, another type of needleless syringe and needleless IV acc Injecting an IV push (bolus) medication; C, another type of needleless syringe and needleless IV acc
Apidium may be ancestral to all later higher primates and is reconstructed as looking like a small-b Apidium may be ancestral to all later higher primates and is reconstructed as looking like a small-b
A patient with Cushing’s syndrome (A) before and (B) after receiving treatment. Sharmyn McGraw A patient with Cushing’s syndrome (A) before and (B) after receiving treatment. Sharmyn McGraw
Wrap the client securely with sheets. (A) Lay one side of the sheet over the body. (B) Enclose the ... Wrap the client securely with sheets. (A) Lay one side of the sheet over the body. (B) Enclose the ...
Building a Client Base Building a Client Base
Testing the client’s ability to feel vibrations, the toe Testing the client’s ability to feel vibrations, the toe
Video: Secondary Active Transport

For a complete list of videos, visit our video library